Is dual antiplatelet therapy beneficial for post-CABG diabetes patients?

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • Routine dual antiplatelet therapy (DAPT) may not be clinically warranted in diabetes patients with multivessel disease undergoing coronary artery bypass grafting (CABG).

Why this matters

  • Diabetes is independently associated with increased perioperative and long-term mortality ...